This signaling increases the expression of CCRK (cycle-related kinase, a direct AR transcriptional target), which results in the activation of the Wnt/β-catenin/TCF (T cell factor) pathway that finally leads to up-expression of AR in HCC cells [117]. Here, AR is linked to hepatocellular carcinoma.